Offering SPR-BLI Services - Proteins provided for free!Get your ComboX free sample to test now!
Fill out organ-on-a-chip questionnaire to win a FREE gift! Fill out organ-on-a-chip questionnaire to win a FREE gift!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Immobilized Human Vitronectin at 5 μg/mL (100 μL/well) can bind Biotinylated Human ITGAV&ITGB3 Heterodimer Protein, His,Avitag&Tag Free (Cat. No. IT3-H82W9) with a linear range of 0.039-2.5 μg/mL (QC tested).
The purity of Rat ITGAV&ITGB3 Heterodimer, His Tag&Tag Free (Cat. No. IT3-R52E2) is more than 85% and the molecular weight of this protein is around 210-240kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Risuteganib | ALG-1001; AM011; AM-011(Allegro Ophthalmics) | Phase 2 Clinical | Allegro Ophthalmics Llc | Diabetic macular oedema; Macular Degeneration; Diabetic Retinopathy | Details |
VIP-236 | VIP-236 | Phase 1 Clinical | Bayer AG | Solid tumours; Neoplasms | Details |
Ga-68 NODAGA-RGD | [68Ga]Theranost; Theranost 68Ga-RGD | Phase 1 Clinical | Advanced Imaging Projects, Zentralklinik Bad Berka, National Cancer Institute | Neovascularization, Pathologic; Prostatic Neoplasms; Contrast agents; Breast Neoplasms; Brain Neoplasms; Lung Neoplasms | Details |
[68Ga]-FF58 | Phase 1 Clinical | Novartis Pharma Ag | Stomach Neoplasms; Esophageal Neoplasms; Glioblastoma; Brain Neoplasms; Carcinoma, Pancreatic Ductal | Details | |
BGC-0222 | BGC0222; BGC-0222 | Phase 1 Clinical | Gaorui Yaoye (Beijing) Technologies Co Ltd, Brightgene Bio-Medical Technology Co Ltd | Solid tumours | Details |
68Ga-FAPI-RGD | 68Ga-FAPI-RGD | Phase 1 Clinical | Peking Union Medical College Hospital | Lung Neoplasms | Details |
Peptide-based PET radiotracer (Stanford University) | Phase 2 Clinical | Stanford University | Breast Neoplasms; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Breast Neoplasms, Male; Tongue Neoplasms; Carcinoma, Squamous Cell; Lymphoma; Laryngeal Neoplasms; Lip Neoplasms; Paranasal Sinus Neoplasms; Mouth Neoplasms; Oropharyngeal Neoplasms; Gliosarcoma; Solid tumours; Brain Neoplasms; Carcinoma, Adenoid Cystic; Glioblastoma; Salivary Gland Neoplasms; Nasopharyngeal Neoplasms; Hypopharyngeal Neoplasms; Colonic Neoplasms; Pancreatic Neoplasms; Granuloma, Lethal Midline; Carcinoma, Renal Cell; Rectal Neoplasms; Carotid Artery Diseases | Details | |
ProAgio | Phase 1 Clinical | National Cancer Institute | Solid tumours; Pancreatic Neoplasms | Details | |
Pagantangentide | Phase 1 Clinical | Nanjing Anji Biological Technology Co Ltd, Jiangsu Aotexin Biomedical Technology Co Ltd, China Pharmaceutical University | Arthritis, Rheumatoid; Rheumatic Diseases | Details | |
Antiangiotide | HM-3; IIM-3 | Phase 1 Clinical | Inner Mongolia Tianqi Pharmaceutical Group Co Ltd, China Pharmaceutical University | Solid tumours; Liver Neoplasms; Stomach Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
ACT-50 | ACT-50 | Phase 1 Clinical | Xiamen Amoytop Biotech Co Ltd | Neoplasms; Carcinoma, Pancreatic Ductal | Details |
(68)Ga-RGD | Phase 1 Clinical | Peking Union Medical College Hospital | Keloid | Details | |
99mTc-3PRGD2 | 99mTc-3PRGD2 | Phase 3 Clinical | Peking University | Lymphatic Metastasis; Lung Neoplasms | Details |
fb-PMT | NP-100; NP-751 | Phase 1 Clinical | NanoPharmaceuticals LLC | Glioma | Details |
IDL-2965 | IDL-2965 | Phase 2 Clinical | Indalo Therapeutics Inc | Non-alcoholic Fatty Liver Disease; Idiopathic Pulmonary Fibrosis | Details |
Transferrin | OCU-200 | Phase 1 Clinical | Ocugen Inc | Wet Macular Degeneration; Diabetic macular oedema; Diabetic Retinopathy | Details |
68Ga-NOTA-BBN-RGD | 68Ga-NOTA-BBN-RGD | Phase 1 Clinical | Peking Union Medical College Hospital | Breast Neoplasms; Prostatic Neoplasms | Details |
68Ga-NOTA-3PTATE-RGD | 68Ga-NOTA-3PTATE-RGD; 68Ga-NOTA-3P-TATE-RGD | Phase 1 Clinical | Peking Union Medical College Hospital | Neuroendocrine Tumors; Lung Neoplasms | Details |
177Lu-FF-58 | 177Lu-FF58; 177-Lu-FF-58; 177Lu-FF-58; [177Lu]Lu-FF58 | Phase 1 Clinical | Advanced Accelerator Applications Sa | Esophageal Neoplasms; Stomach Neoplasms; Glioblastoma; Carcinoma, Pancreatic Ductal | Details |
Alfatide[18F] | 18F-AlF-NOTA-PRGD2; 18F-alfatide; alfatide II; AlF-NOTA-PRGD2-[18F] | Phase 3 Clinical | Jiangsu Smk Pharmaceutical Co Ltd, Taizhou Kairui Pharmaceutical Technology Co Ltd | Carcinoma, Bronchogenic; Head and Neck Neoplasms; Neoplasms; Soft Tissue Neoplasms; Breast Neoplasms; Contrast agents; Lymphoma | Details |
AS-101 | PRX-0001/AS101; WAX-120337; IVAX-Q-101; IVX-Q-101; CB-06-02; AS-101; PRX-001; PRX-0002/AS101 | Phase 2 Clinical | Biomas Ltd | Alopecia; HIV Infections; Warts; Myelodysplastic Syndromes; Psoriasis; Leukemia, Myeloid, Acute; Thrombocytopenia; Macular Degeneration; Dermatitis, Atopic; Condylomata Acuminata | Details |
68Ga-HX01 | 68GaHX01; 68Ga-HX01 | Phase 1 Clinical | Hexin (Suzhou) Pharmaceutical Technology Co Ltd | Solid tumours; Contrast agents | Details |
Nesvategrast | OTT-166(OcuTerra Therapeutics); SF-0166 | Phase 2 Clinical | Scifluor Life Sciences Inc, OcuTerra Therapeutics Inc | Diabetic macular oedema; Diabetic Retinopathy; Macular Degeneration | Details |
Internalized-arginylglycylaspartic acid cyclic peptide | CEND-1; iRGD; CIND-1; LSTA1; QLC12102 | Phase 2 Clinical | Drugcendr Inc | Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Hypopharyngeal Neoplasms; Triple Negative Breast Neoplasms; Pancreatic Neoplasms; Colonic Neoplasms; Cholangiocarcinoma; Breast Neoplasms; Bile Duct Neoplasms; Oropharyngeal Neoplasms; Carcinoma, Squamous Cell; Gallbladder Neoplasms; Laryngeal Neoplasms; Mouth Neoplasms; Appendiceal Neoplasms; Carcinoma, Pancreatic Ductal | Details |
This web search service is supported by Google Inc.